首页> 外文OA文献 >Prevention of Bloodstream Infections With Central Venous Catheters Treated With Anti-Infective Agents Depends on Catheter Type and Insertion Time: Evidence From a Meta-Analysis
【2h】

Prevention of Bloodstream Infections With Central Venous Catheters Treated With Anti-Infective Agents Depends on Catheter Type and Insertion Time: Evidence From a Meta-Analysis

机译:用抗感染药治疗中心静脉导管预防血流感染取决于导管类型和插入时间:荟萃分析的证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To test the evidence that the risk of infection related to central venous catheters (CVCs) is decreased by anti-infective coating or cuffing. Design: Systematic review of randomized, controlled trials comparing anti-infective with inactive (control) CVCs. Interventions: Average insertion times were taken as a measurement of the length of insertion. Dichotomous data were combined using a fixed effect model and expressed as odds ratio (OR) with 95% confidence interval (CI95). Results: Two trials on antibiotic coating (343 CVCs) had an average insertion time of 6 days; the risk of BSI decreased from 5.1% with control to 0% with anti-infective catheters. There were no trials with longer average insertion times. In three trials on silver collagen cuffs (422 CVCs), the average insertion time ranged from 5 to 8.2 days (median, 7 days); the risk of BSI was 5.6% with control and 3.2% with anti-infective catheters. In another trial on silver collagen cuffs (101 CVCs), the average insertion time was 38 days; the risk of BSI was 3.7% with control and 4.3% with anti-infective catheters. In five trials on chlorhexidine-silver sulfadiazine coating (1,269 CVCs), the average insertion time ranged from 5.2 to 7.5 days (median, 6 days); the risk of BSI decreased from 4.1% with control to 1.9% with anti-infective catheters. In five additional trials on chlorhexidine-silver sulfadiazine coating (1,544 CVCs), the average insertion time ranged from 7.8 to 20 days (median, 12 days); the risk of BSI was 4.5% with control and 4.2% with anti-infective catheters. Conclusions: Antibiotic and chlorhexidine-silver sulfadiazine coatings are anti-infective for short (approximately 1 week) insertion times. For longer insertion times, there are no data on antibiotic coating, and there is evidence of lack of effect for chlorhexidine-silver sulfadiazine coating. For silver-impregnated collagen cuffs, there is evidence of lack of effect for both short- and long-term insertion
机译:目的:测试证据,证明抗感染涂层或袖带可降低与中央静脉导管(CVC)相关的感染风险。设计:比较抗感染和无效(对照)CVC的随机对照试验的系统评价。干预措施:平均插入时间用作插入长度的量度。使用固定效应模型合并二分数据,并以具有95%置信区间(CI95)的优势比(OR)表示。结果:两项关于抗生素涂层(343 CVC)的试验平均插入时间为6天。 BSI的风险从对照组的5.1%降至抗感染导管的0%。没有试验具有更长的平均插入时间。在三项关于银胶原袖带(422个CVC)的试验中,平均插入时间为5到8.2天(中位数为7天)。对照的BSI风险为5.6%,抗感染的导管为3.2%。在另一项关于银胶原袖套(101个CVC)的试验中,平均插入时间为38天;对照组的BSI风险为3.7%,抗感染导管的BSI风险为4.3%。在对洗必泰-磺胺嘧啶银涂层(1,269个CVC)进行的五项试验中,平均插入时间为5.2至7.5天(中位数为6天)。 BSI的风险从对照组的4.1%降至使用抗感染导管的1.9%。在洗必太银磺胺嘧啶银涂层(1,544个CVC)的另外5个试验中,平均插入时间为7.8至20天(中位数为12天)。对照组的BSI风险为4.5%,抗感染导管的BSI风险为4.2%。结论:抗生素和洗必泰银磺胺嘧啶涂层在短时间内(约1周)具有抗感染性。对于更长的插入时间,没有抗生素涂层的数据,并且有证据表明氯己定-银磺胺嘧啶涂层缺乏作用。对于浸渍银的胶原袖带,有证据表明短期和长期插入均无效

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号